New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|May 1, 2000
Supplements and Featured Publications
- Emerging Drug-Resistant Pathogens in Respiratory Tract Infections: Treatment Options
- Volume 6
- Issue 8 Suppl
The Role of Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Author(s)Robert E. Hillberg, MD
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
Emerging Resistance Problems Among Respiratory Tract Pathogensover 26 years ago
The Importance of Appropriate Treatment of Chronic Bronchitisover 26 years ago
Selected Abstractsover 26 years ago
BibliographyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Roundtables reveal HFpEF/HFmrEF care lags despite rising cases; learn new SGLT2/MRA strategies, screening, and scalable team pathways.
Advertisement
Advertisement
Trending on AJMC
1
Regorafenib Prescribing in Advanced GIST Deviates From Guidelines
2
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
3
Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD
4
Specialty Pharmacy Leaders to Convene for NASP inSPire2026
5